Novum Pharmaceutical Research Services, a subsidiary of Lambda Therapeutic Research, is a CRO with over 50 years of experience in the industry. Lambda & Novum deliver comprehensive, end-to-end clinical research services to the innovator, biotech, and generic pharmaceutical industries worldwide.
With a focus on secure IT infrastructure and automation, we ensure timely project delivery and strict adherence to global regulatory standards. Our exemplary regulatory track record includes over 60 successful international inspections and audits by esteemed authorities such as the USFDA, EMEA, MHRA, EU member states, and other global bodies over the past five years.
We look forward to showcasing how our extensive experience and expertise in drug development can drive your project’s success. Take the opportunity to meet our representatives Dr. Netal Desai (Vice President, Clinical Operations & Business Development) & Ms. Cathy Lopez (Vice President, Business Development) and discuss how we can customize our full-service capabilities to meet your specific needs.
Meet us at DCAT Week 2026
Novum Pharmaceutical Research Services and Lambda Therapeutic Research are excited to announce their participation in DCAT Week 2026, at New York City, which will take place from 23 to 26 March 2026.
Schedule a meeting by filling out the form or reach out at to discuss how Lambda and Novum can support your drug development projects.